🇺🇸 FDA

Intelligence · Patent portfolio

BioMarin Pharmaceutical Australia Patents

Full USPTO pharma patent portfolio for BioMarin Pharmaceutical Australia — grant dates, expiration, and drug cross-links.

Patents
175
Expiring ≤24m
2

Quick answer

BioMarin Pharmaceutical Australia has 175 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 2 expire within 24 months — use filters for patent-cliff planning.

Page 1 of 4

  1. US 12427171

    Krill oil composition enriched in LPC-DHA and LPC-EPA

    Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12331293

    Bispecific antisense oligonucleotides for dystrophin exon skipping

    Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12239692

    Adeno-associated virus factor VIII vectors

    Expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12233106

    C-type natriuretic peptide variants to treat skeletal dysplasia in children

    Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12214015

    Use of c-type natriuretic peptide variants to treat osteoarthritis

    Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12194064

    Process of producing concentrated therapeutic phospholipid composition from krill extracts containing high level of free fatty acids

    Expires Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12188058

    Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof

    Expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12076372

    Use of C-type natriuretic peptide variants to treat skeletal dysplasia

    Expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 12076333

    Lysophosphatidylcholine compositions

    Expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 12023359

    Phospholipid compositions for delivery of therapeutic compounds

    Expires Mon Jun 27 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11918633

    Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating adolescent subjects

    Expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11911446

    Use of C-type natriuretic peptide variants to treat skeletal dysplasia

    Expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11865143

    Bioeffective krill oil compositions

    Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11819509

    Lipid compositions

    Expires Mon Nov 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11821008

    Liver targeting adeno-associated viral vectors

    Expires Mon Nov 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11739345

    Methods of treating phenylketonuria

    Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11690898

    Adeno-associated virus Factor VIII vectors, associated viral particles and therapeutic formulations comprising the same

    Expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11590204

    Use of C-type natriuretic peptide variants to treat skeletal dysplasia

    Expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11584780

    Adeno-associated virus capsid proteins

    Expires Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11505790

    Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof

    Expires Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11427820

    Methods and means for efficient skipping of exon 45 in Duchenne muscular dystrophy pre-mRNA

    Expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11406690

    Adeno-associated virus factor VIII vectors

    Expires Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11400105

    Anti-inflammatory properties of marine lipid compositions

    Expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11384055

    Glycolate oxidase inhibitors for the treatment of disease

    Expires Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11358932

    N-(1-hydroxy-3-(pyrrolidinyl)propan-2-yl)pyrrolidine-3-carboxamide derivatives as glucosylceramide synthase inhibitors

    Expires Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11351231

    Lysosomal targeting peptides and uses thereof

    Expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11345904

    Targeted therapeutic lysosomal enzyme fusion proteins, associated formulations and uses thereof

    Expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 11254725

    Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof

    Expires Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 11229687

    TPP-1 formulations and methods for treating CLN2 disease

    Expires Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 11202819

    Use of C-type natriuretic peptide variants to treat osteoarthritis

    Expires Mon Dec 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 11147841

    Enhanced omega-3 formulations

    Expires Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 11135251

    Methods for improving fillet quality in farmed fish

    Expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 11065267

    Lysophosphatidylcholine compositions

    Expires Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 11040088

    Delivery of therapeutic compounds to the brain and other tissues

    Expires Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 11034956

    Oligonucleotide comprising an inosine for treating DMD

    Expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 11020438

    Phospholipid compositions and their preparation

    Expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 10960016

    Capsules containing high doses of krill phospholipids

    Expires Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 10934534

    Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof

    Expires Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 10913946

    RNA modulating oligonucleotides with improved characteristics for the treatment of Duchenne and Becker muscular dystrophy

    Expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 10898525

    Krill oil preparations and their uses

    Expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 10876114

    Methods and means for efficient skipping of at least one of the following exons of the human Duchenne muscular dystrophy gene: 43, 46, 50-53

    Expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 10864223

    Lipid compositions

    Expires Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 10851058

    Histone deacetylase inhibitors

    Expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 10806742

    Liquid phospholipid-containing compositions for the preparation of pharmaceuticals

    Expires Mon Oct 15 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 10758598

    TPP-1 formulations and methods for treating CLN2 disease

    Expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 10689646

    Treatment of genetic disorders associated with DNA repeat instability

    Expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 10683530

    Detection of oligosaccharides

    Expires Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 10653725

    Methods for improving health of farmed fish

    Expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does BioMarin Pharmaceutical Australia have?

175 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do BioMarin Pharmaceutical Australia patents expire?

2 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.